Comparison Overview

ABODE Treatment, INC.

VS

Multipharma

ABODE Treatment, INC.

5601 Bridge St, 490, Fort Worth, Texas, US, 76112
Last Update: 2025-11-26
Between 750 and 799

ABODE Treatment, Inc. believes that chemical dependency is an insidious and progressive disease. Multiple studies have indicated that the majority of individuals involved in the criminal justice system are involved with the use/abuse of mood-altering chemicals. Many of these individuals have social developmental deficiencies, as well as educational and vocational disadvantages. ABODE Treatment, Inc. further believes that these individuals can and do recover from the disease of chemical dependency with appropriate treatment. Further, ABODE Treatment, Inc. believes that the criminal population can obtain and maintain the social and vocational skills necessary to survive in the free world without resorting to chemicals or crime to help inadequate coping skills.

NAICS: 923
NAICS Definition: Administration of Human Resource Programs
Employees: 42
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Multipharma

Square Marie Curie 30, Anderlecht, 1070, BE
Last Update: 2025-11-22
Between 750 and 799

Multipharma makes pharmaceutical care accessible to everyone. As the most important cooperative in the Belgian pharmacy world, we care for 1.3 million patients every day. With more than 320 pharmacies, 2 distribution centres and 2 innovative centres that package medicines by dose and time for individual patients, we do more than simply supply medicines. We contribute to the future and innovation of pharmaceutical care. Both in the pharmacy and beyond, we invest heavily in technological innovations to simplify the supply of medication, so that our pharmacists can devote more time to personal advice and specific care tasks. Whether working in the pharmacy or providing services to residential care homes and other healthcare facilities, our goal is always the same: to put our patients’ health first. More than 2200 dedicated staff help us do exactly that.

NAICS: 923
NAICS Definition: Administration of Human Resource Programs
Employees: 1,277
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/abode-treatment-inc.jpeg
ABODE Treatment, INC.
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/multipharma.jpeg
Multipharma
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
ABODE Treatment, INC.
100%
Compliance Rate
0/4 Standards Verified
Multipharma
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Health and Human Services Industry Average (This Year)

No incidents recorded for ABODE Treatment, INC. in 2025.

Incidents vs Health and Human Services Industry Average (This Year)

No incidents recorded for Multipharma in 2025.

Incident History — ABODE Treatment, INC. (X = Date, Y = Severity)

ABODE Treatment, INC. cyber incidents detection timeline including parent company and subsidiaries

Incident History — Multipharma (X = Date, Y = Severity)

Multipharma cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/abode-treatment-inc.jpeg
ABODE Treatment, INC.
Incidents

No Incident

https://images.rankiteo.com/companyimages/multipharma.jpeg
Multipharma
Incidents

No Incident

FAQ

Both ABODE Treatment, INC. company and Multipharma company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

Historically, Multipharma company has disclosed a higher number of cyber incidents compared to ABODE Treatment, INC. company.

In the current year, Multipharma company and ABODE Treatment, INC. company have not reported any cyber incidents.

Neither Multipharma company nor ABODE Treatment, INC. company has reported experiencing a ransomware attack publicly.

Neither Multipharma company nor ABODE Treatment, INC. company has reported experiencing a data breach publicly.

Neither Multipharma company nor ABODE Treatment, INC. company has reported experiencing targeted cyberattacks publicly.

Neither ABODE Treatment, INC. company nor Multipharma company has reported experiencing or disclosing vulnerabilities publicly.

Neither ABODE Treatment, INC. nor Multipharma holds any compliance certifications.

Neither company holds any compliance certifications.

Neither ABODE Treatment, INC. company nor Multipharma company has publicly disclosed detailed information about the number of their subsidiaries.

Multipharma company employs more people globally than ABODE Treatment, INC. company, reflecting its scale as a Health and Human Services.

Neither ABODE Treatment, INC. nor Multipharma holds SOC 2 Type 1 certification.

Neither ABODE Treatment, INC. nor Multipharma holds SOC 2 Type 2 certification.

Neither ABODE Treatment, INC. nor Multipharma holds ISO 27001 certification.

Neither ABODE Treatment, INC. nor Multipharma holds PCI DSS certification.

Neither ABODE Treatment, INC. nor Multipharma holds HIPAA certification.

Neither ABODE Treatment, INC. nor Multipharma holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.

Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H